S&P 500 (NYSE:SPY) component Amgen (NASDAQ:AMGN) will unveil its latest earnings tomorrow, Wednesday, January 23, 2013. Amgen is a biotechnology medicines company that discovers, develops, manufactures, and markets medicines for grave illnesses.
Amgen Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for net income of $1.43 per share, a rise of 20.2% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved up from $1.39. Between one and three months ago, the average estimate moved up. It has dropped from $1.47 during the last month. Analysts are projecting profit to rise by 23.9% compared to last year’s $6.49.
Past Earnings Performance: The company’s quarterly results have come in above estimates for the last three quarters. Last quarter, the company booked profit of $1.67 per share versus a mean estimate of net income of $1.43 per share.
Start 2013 better than ever by saving time and making money with your Limited Time Offer for our highly-acclaimed Stock Picker Newsletter. Click here for our fresh Feature Stock Pick now!
A Look Back: In the third quarter, profit rose more than twofold to $1.11 billion ($1.41 a share) from $454 million (50 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 9.5% to $4.32 billion from $3.94 billion.
Here’s how Amgen traded following its last earnings report 3 months ago and leading up to its upcoming earnings report this week: